BBOT
BridgeBio Oncology
BBOT
BBOT
31 hedge funds and large institutions have $186M invested in BridgeBio Oncology in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.23M | |
| 2 | +$3.04M | |
| 3 | +$1.72M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.13M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$1.13M |
Top Sellers
| 1 | -$5.25M | |
| 2 | -$3.67M | |
| 3 | -$2.63M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.43M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.15M |